|
FDX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.57720999999222E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.796000E-02 |
| Stage1-vs-Stage3 |
8.783500E-02 |
| Stage1-vs-Stage4 |
4.3105999880666E-09 |
| Stage2-vs-Stage3 |
4.138600E-03 |
| Stage2-vs-Stage4 |
2.19940000001362E-06 |
| Stage3-vs-Stage4 |
9.968400E-04 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.74789999999914E-05 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
5.316600E-01 |
| Caucasian-vs-Asian |
3.225600E-01 |
| AfricanAmerican-vs-Asian |
3.614000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
4.416000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.84341431008761E-12 |
| Normal-vs-Age(81-100Yrs) |
1.71717999999377E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.661600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.152600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.275800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.131600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.823400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.697400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.02080000000815E-05 |
| Classical-VS-Follicular |
1.44470000407182E-08 |
| Classical-VS-Other |
9.174200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
2.03848049551425E-12 |
| Tall-VS-Other |
6.666200E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.279700E-03 |
| Follicular-VS-Normal |
1.88297000000004E-05 |
| Other-VS-Normal |
1.55447999999891E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-16 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
7.36439999982075E-07 |
|
|
